| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0853f14a64b16d1710f4315d150da980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f240e05e1e173b54450ba119beec2206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c980c912af0e0dce6851b1162f685739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42adc98cc735488cf08a27c74af3245f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c05b281a31a5053a86e2fa3919fc32b1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2010-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf30520ea140220168c9327d9dfa76f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e069d179c05ca82715a49160a8d3fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c2ff824e7608ccb7f4568af17f908e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_097bcc5b2fee0d4b0196c79329cde5f1 |
| publicationDate |
2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8298542-B2 |
| titleOfInvention |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia |
| abstract |
The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques. |
| priorityDate |
2001-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |